Market News

Indian equity benchmarks extended their winning streak on 28 January, buoyed by the historic India–European Union Free Trade Agreement (FTA) and a strong pre-budget rally in capital expenditure-linked sectors. Check why the benchmarks have now climbed about 1% over the last two sessions.

Hindalco Industries has announced a ₹21,000 crore expansion of its aluminium smelter capacity at Aditya Aluminium complex in Odisha. The project includes commissioning India’s first battery-grade aluminium foil facility, which will support both the electric vehicle and energy storage supply chains.

Indian markets closed higher as optimism around the India-EU trade deal lifted sentiment despite elevated volatility. As investors assess sector-specific implications and await further earnings cues, trading is likely to remain selective and stock-specific.

India and Canada have agreed to expand two-way trade in oil, gas, and petroleum products as part of their ongoing energy reset and diplomatic restoration. The agreement includes higher shipments of crude oil, LNG, and LPG to India, while Canada will resume exports of refined petroleum products.

Kanohar Electricals has filed draft IPO papers with SEBI. The funds are intended for expansion, capital expenditure, and working capital. The company has reported strong growth in both revenue and profits.

President Droupadi Murmu’s pre-Budget address set the tone for Budget 2026, highlighting inclusive growth, welfare, and economic stability, while sharp political protests hinted at heated debates ahead in Parliament.

Adani Group stocks jumped up to 6% intraday on 27 January 2026, rebounding from the previous sell-off on an aviation partnership announcement and a US regulatory update.

Shares of alcoholic and non-alcoholic beverage companies declined as investors reacted to the India-EU trade agreement and the possibility of higher competition from European players.

Markets recovered after intraday swings, with Nifty holding above 25,150 and Sensex gaining, led mainly by metals and financials, while broader participation stayed uneven. Earnings reactions, currency movement, and the India–EU trade deal shaped sentiment, making it a positive close on the surface but a selective market underneath.

Sun Pharma and Cipla’s USFDA recalls bring into the picture the rising regulatory scrutiny on Indian drugmakers. There are limited health risks, but still, the actions indicate the expectations of stricter complications. This raises concerns for pharma exporters, investors and India’s credibility in the U.S market.